propranolol has been researched along with Kidney Diseases in 41 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Excerpt | Relevance | Reference |
|---|---|---|
| " In a double-blind cross-over study the antihypertensive action and side-effects of labetalol and propranolol were compared in 18 previously untreated outpatients with hypertension, WHO stage I--III." | 9.05 | Labetalol in the treatment of hypertension in patients with normal and impaired renal function. ( Berg, KJ; Nilsen, OG; Walstad, RA; Wessel-Aas, T, 1982) |
| "1 Pindolol and propranolol were administered orally in equipotent antihypertensive doses to 14 subjects with mild to moderate hypertension in an open cross-over study." | 9.05 | Effect of pindolol and propranolol on renal function of patients with hypertension. ( Pasternack, A; Pörsti, P; Pöyhönen, L, 1982) |
| "Studies were carried out in 15 patients with renal insufficiency and hypertension to compare the long-term effects of methyldopa and propranolol on renal hemodynamics." | 7.67 | Comparison of long-term renal hemodynamic effects of methyldopa and propranolol in patients with hypertension and renal insufficiency. ( Alterman, L; Bank, DE; Bank, N; Lowenstein, I; Zelen, R, 1984) |
| " In a double-blind cross-over study the antihypertensive action and side-effects of labetalol and propranolol were compared in 18 previously untreated outpatients with hypertension, WHO stage I--III." | 5.05 | Labetalol in the treatment of hypertension in patients with normal and impaired renal function. ( Berg, KJ; Nilsen, OG; Walstad, RA; Wessel-Aas, T, 1982) |
| "1 Pindolol and propranolol were administered orally in equipotent antihypertensive doses to 14 subjects with mild to moderate hypertension in an open cross-over study." | 5.05 | Effect of pindolol and propranolol on renal function of patients with hypertension. ( Pasternack, A; Pörsti, P; Pöyhönen, L, 1982) |
| "Minoxidil was used to treat 26 patients (17 to 67 years old) with severe hypertension and varying degrees of renal function." | 5.04 | Long-term clinical effects, bioavailability, and kinetics of minoxidil in relation to renal function. ( Affrime, M; Busby, P; Kim, KE; Lowenthal, DT; Martinez, EW; Mutterperl, R; Onesti, G; Shirk, J; Swartz, C, 1978) |
| " However, nipradilol, at doses of 10 and 15 mg/kg/day, significantly decreased proteinuria and glomerulosclerosis, while propranolol did not." | 3.72 | A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol. ( Hasuike, Y; Hiraoka, K; Inoue, T; Itahana, R; Izumi, M; Miyagawa, K; Nakanishi, T; Nishihara, F; Takamitsu, Y, 2003) |
| " Serum angiotensin converting enzyme activity (ACEA) and plasma renin activity (PRA) were determined in rats under different experimental conditions such as: nephrotic syndrome (NS), bilateral nephrectomy (BN), renovascular hypertension (RH), dehydration (DEH), anaesthesia (AN), low sodium diet (LSD) and high sodium diet (HSD), and injection with propranolol (PRO) and isoprenaline (ISO)." | 3.68 | Serum angiotensin converting enzyme activity and plasma renin activity in experimental models of rats. ( Cruz, C; Ibarra-Rubio, ME; Pedraza-Chaverrí, J; Peña, JC; Tapia, E, 1990) |
| "Studies were carried out in 15 patients with renal insufficiency and hypertension to compare the long-term effects of methyldopa and propranolol on renal hemodynamics." | 3.67 | Comparison of long-term renal hemodynamic effects of methyldopa and propranolol in patients with hypertension and renal insufficiency. ( Alterman, L; Bank, DE; Bank, N; Lowenstein, I; Zelen, R, 1984) |
| "The mechanisms responsible for the increased bioavailability of propranolol in renal dysfunction were investigated in rats." | 1.32 | The increased intestinal absorption rate is responsible for the reduced hepatic first-pass extraction of propranolol in rats with cisplatin-induced renal dysfunction. ( Aiba, T; Hashimoto, Y; Mizukami, A; Okabe, H; Taguchi, M; Yasuhara, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 35 (85.37) | 18.7374 |
| 1990's | 2 (4.88) | 18.2507 |
| 2000's | 3 (7.32) | 29.6817 |
| 2010's | 1 (2.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Avdeef, A | 1 |
| Tam, KY | 1 |
| Takamitsu, Y | 1 |
| Nakanishi, T | 1 |
| Nishihara, F | 1 |
| Hasuike, Y | 1 |
| Izumi, M | 1 |
| Inoue, T | 1 |
| Hiraoka, K | 1 |
| Itahana, R | 1 |
| Miyagawa, K | 1 |
| Okabe, H | 1 |
| Mizukami, A | 1 |
| Taguchi, M | 1 |
| Aiba, T | 1 |
| Yasuhara, M | 1 |
| Hashimoto, Y | 1 |
| TSOLAKAS, TC | 1 |
| DAVIES, JP | 1 |
| ORAM, S | 1 |
| Varela, JA | 1 |
| Epstein, M | 1 |
| Oster, JR | 1 |
| Balant, LP | 1 |
| Dayer, P | 1 |
| Fabre, J | 1 |
| Coevoet, B | 1 |
| Lambrey, G | 1 |
| de Frémont, JF | 1 |
| Hardin, JM | 1 |
| Desplan, C | 1 |
| Calmette, C | 1 |
| Makdassi, R | 1 |
| Andrejak, M | 1 |
| Moukhtar, MS | 1 |
| Fournier, A | 1 |
| Lowenstein, I | 1 |
| Alterman, L | 1 |
| Zelen, R | 1 |
| Bank, DE | 1 |
| Bank, N | 1 |
| Walstad, RA | 1 |
| Berg, KJ | 1 |
| Wessel-Aas, T | 1 |
| Nilsen, OG | 1 |
| Wilkinson, R | 1 |
| Sellars, L | 1 |
| Pickering, M | 1 |
| Robson, V | 1 |
| Kerr, DN | 1 |
| Pasternack, A | 1 |
| Pörsti, P | 1 |
| Pöyhönen, L | 1 |
| al-Damluji, S | 1 |
| Meek, JH | 1 |
| Markenson, JA | 1 |
| Sherman, RL | 1 |
| Naess, K | 1 |
| Bühler, FR | 2 |
| Burkart, F | 1 |
| Lütold, BE | 1 |
| Küng, M | 1 |
| Marbet, G | 1 |
| Pfisterer, M | 1 |
| Lowenthal, DT | 1 |
| Onesti, G | 1 |
| Mutterperl, R | 1 |
| Affrime, M | 1 |
| Martinez, EW | 1 |
| Kim, KE | 1 |
| Busby, P | 1 |
| Shirk, J | 1 |
| Swartz, C | 1 |
| McGrath, BP | 1 |
| Tiller, DJ | 1 |
| Bune, A | 1 |
| Chalmers, JP | 1 |
| Korner, PI | 1 |
| Uther, JB | 1 |
| Cecchettin, M | 1 |
| Albertini, A | 1 |
| Mioni, G | 1 |
| Castellani, A | 1 |
| Cristinelli, L | 1 |
| Maiorca, R | 1 |
| Heynen, G | 1 |
| Franchimont, P | 1 |
| Börner, H | 1 |
| Falkenhagen, D | 1 |
| Rohmann, H | 1 |
| Krüger, M | 1 |
| Russell, SB | 1 |
| Woods, JR | 1 |
| Brinkman, CR | 1 |
| Birkenhäger, WH | 1 |
| Wester, A | 1 |
| Ibarra-Rubio, ME | 1 |
| Cruz, C | 1 |
| Tapia, E | 1 |
| Peña, JC | 1 |
| Pedraza-Chaverrí, J | 1 |
| Isozaki, S | 1 |
| Wells, TG | 1 |
| Ulstrom, RA | 1 |
| Nevins, TE | 1 |
| Wood, M | 1 |
| Norès, JM | 1 |
| Lignières, G | 1 |
| Tcherdakoff, P | 1 |
| Moreira, J | 1 |
| Barata, JD | 1 |
| Olias, J | 1 |
| Kincaid-Smith, P | 1 |
| Hua, AS | 1 |
| Doherty, JE | 1 |
| Kane, JJ | 1 |
| Modlinger, RS | 1 |
| Nicolis, GL | 1 |
| Krakoff, LR | 1 |
| Gabrilove, JL | 1 |
| Frohlich, ED | 1 |
| Tarazi, RC | 2 |
| Dustan, HP | 1 |
| Aroesty, JM | 1 |
| Cohen, SI | 1 |
| Morkin, E | 1 |
| Pohl, JE | 1 |
| Thurston, H | 1 |
| Swales, JD | 1 |
| Kessler, KM | 1 |
| Levy, RH | 1 |
| Smith, GH | 1 |
| Laragh, JH | 1 |
| Vaughan, ED | 1 |
| Brunner, HR | 1 |
| Gavras, H | 1 |
| Baer, L | 1 |
| Schwartz, GJ | 1 |
| Cornfeld, D | 1 |
| Lehr, D | 1 |
| Krukowski, M | 1 |
| Colón, R | 1 |
5 reviews available for propranolol and Kidney Diseases
| Article | Year |
|---|---|
Beta-blockers and the kidney.
Topics: Adrenergic beta-Antagonists; Animals; Antihypertensive Agents; Cardiac Output; Glomerular Filtration | 1982 |
Consequences of renal insufficiency on the hepatic clearance of some drugs.
Topics: Adrenergic beta-Antagonists; Biotransformation; Dextropropoxyphene; Ethanolamines; Humans; Kidney Di | 1983 |
Plasma drug binding: implications for anesthesiologists.
Topics: Age Factors; Alfentanil; Alprenolol; Anesthesia; Anesthetics; Blood Proteins; Bupivacaine; Burns; Ca | 1986 |
Clinical pharmacology and therapeutics use of digitalis glycosides.
Topics: Adenosine Triphosphatases; Arrhythmias, Cardiac; Digitalis Glycosides; Digitoxin; Digoxin; Heart; He | 1973 |
Individualization of dosage of antiarrhythmic drugs.
Topics: Dose-Response Relationship, Drug; Drug Interactions; Electrocardiography; Heart Diseases; Humans; Ki | 1974 |
4 trials available for propranolol and Kidney Diseases
| Article | Year |
|---|---|
Labetalol in the treatment of hypertension in patients with normal and impaired renal function.
Topics: Adult; Aged; Double-Blind Method; Ethanolamines; Female; Half-Life; Humans; Hypertension; Kidney Dis | 1982 |
Effect of pindolol and propranolol on renal function of patients with hypertension.
Topics: Adult; Female; Humans; Hypertension; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Pind | 1982 |
Long-term clinical effects, bioavailability, and kinetics of minoxidil in relation to renal function.
Topics: Adolescent; Adult; Aged; Biological Availability; Blood Pressure; Clinical Trials as Topic; Female; | 1978 |
Beta-adrenergic blocking therapy in hypertension: selection of patients.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Blood Volume; Body Surface Area; Cardiac Output; | 1970 |
32 other studies available for propranolol and Kidney Diseases
| Article | Year |
|---|---|
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological | 2010 |
A nitric oxide-generating beta-blocking agent prevents renal injury in the rat remnant kidney model. Comparative study of two beta-blocking drugs, nipradilol and propranolol.
Topics: Adrenergic beta-Antagonists; Animals; Cyclic GMP; Enzyme Inhibitors; Hypertension; Kidney; Kidney Di | 2003 |
The increased intestinal absorption rate is responsible for the reduced hepatic first-pass extraction of propranolol in rats with cisplatin-induced renal dysfunction.
Topics: Adrenergic beta-Antagonists; Animals; Biological Availability; Cisplatin; Dose-Response Relationship | 2003 |
PROPRANOLOL IN ATTEMPTED MAINTENANCE OF SINUS RHYTHM AFTER ELECTRICAL DEFIBRILLATION.
Topics: Atrial Fibrillation; Chemical and Drug Induced Liver Injury; Electric Countershock; Hepatitis; Human | 1964 |
[Rapid preoperative preparation with iopanoic acid in severe liver toxicity due to methimazole: anesthetic implications].
Topics: Adrenergic beta-Antagonists; Adult; Anesthesia, Intravenous; Antithyroid Agents; Chemical and Drug I | 2008 |
[Evidence, in uremic man, of the role of beta 2 adrenergic receptors in the secretion of parathyroid hormone and calcitonin (author's transl)].
Topics: Adult; Calcitonin; Female; Heart Rate; Humans; Kidney Diseases; Male; Metoprolol; Parathyroid Hormon | 1980 |
Comparison of long-term renal hemodynamic effects of methyldopa and propranolol in patients with hypertension and renal insufficiency.
Topics: Adult; Aged; Aldosterone; Blood Pressure; Female; Furosemide; Humans; Hypertension; Kidney Diseases; | 1984 |
The relative roles of sodium and renin in the hypertension of renal disease. An assessment based on the response to frusemide and propranolol.
Topics: Adolescent; Adult; Aged; Creatinine; Female; Furosemide; Humans; Hypertension, Renal; Kidney Disease | 1981 |
Interference of a propranolol metabolite with serum bilirubin estimation in chronic renal failure.
Topics: Bilirubin; Chronic Disease; Humans; Kidney Diseases; Propranolol | 1980 |
Renal involvement in progressive systemic sclerosis: prolonged survival with aggressive antihypertensive management.
Topics: Adult; Antihypertensive Agents; Cardiomegaly; Digoxin; Drug Therapy, Combination; Female; Furosemide | 1979 |
[Adrenergic beta receptor blockaders].
Topics: Adrenergic beta-Antagonists; Anesthesia; Asthma; Bronchial Spasm; Conjunctivitis; Hypoglycemia; Hypo | 1975 |
Antihypertensive beta blocking action as related to renin and age: a pharmacologic tool to identify pathogenetic mechanisms in essential hypertension.
Topics: Adrenergic beta-Antagonists; Adult; Age Factors; Blood Pressure; Female; Hemodynamics; Humans; Hyper | 1975 |
Autonomic blockade and the Valsalva maneuver in patients on maintenance hemodialysis: a hemodynamic study.
Topics: Adult; Aldosterone; Atropine; Blood Pressure; Blood Volume; Cardiac Output; Chronic Disease; Female; | 1977 |
[Hypersecretion of calcitonin in hypocalcemic syndromes and in stimulation of the autonomic nervous system].
Topics: Autonomic Nervous System; Calcitonin; Calcium; Ethanol; Gastrins; Humans; Hypocalcemia; Insulin; Ins | 1977 |
[Behavior of plasms renin activity, hemodynamic parameters and clearance values as influenced by orciprenaline and propranolol in patients with limited kidney function].
Topics: Adult; Angina Pectoris; Chronic Disease; Female; Glomerulonephritis; Hemodynamics; Humans; Kidney Di | 1976 |
The mechanism of action of mercuric chloride on the isolated perfused rat kidney.
Topics: Angiotensin II; Animals; Bradykinin; Chlorides; Kidney Diseases; Male; Mannitol; Mercury; Mercury Po | 1975 |
The treatment of gestational hypertension.
Topics: Antihypertensive Agents; Chronic Disease; Diazoxide; Female; Humans; Hydralazine; Hypertension; Hype | 1975 |
[A question of logic].
Topics: Diazoxide; Furosemide; Humans; Hyperaldosteronism; Hypertension; Kidney Diseases; Male; Middle Aged; | 1976 |
Serum angiotensin converting enzyme activity and plasma renin activity in experimental models of rats.
Topics: Animals; Disease Models, Animal; Hypertension, Renovascular; Isoproterenol; Kidney Diseases; Male; N | 1990 |
[Therapeutic drug monitoring of propranolol hydrochloride].
Topics: Administration, Oral; Aged; Aged, 80 and over; Biological Availability; Chromatography, Gas; Chromat | 1990 |
Hypoglycemia in pediatric renal allograft recipients.
Topics: Child; Child, Preschool; Diuretics; Female; Follow-Up Studies; Graft Rejection; Humans; Hypoglycemia | 1988 |
[Hypertension in pregnant women and beta-blockers. Follow-up of 31 pregnancies].
Topics: Adult; Blood Pressure; Embryonic and Fetal Development; Female; Follow-Up Studies; Humans; Hypertens | 1988 |
Antihypertensive action of calcium blockade in hypertensive patients with chronic renal disease.
Topics: Adult; Aged; Blood Pressure; Chronic Disease; Drug Therapy, Combination; Female; Humans; Hypertensio | 1985 |
Letter: Beta-adrenergic blocking agents in renal failure.
Topics: Adrenergic beta-Antagonists; Creatinine; Glomerulonephritis; Humans; Hypertension; Kidney Diseases; | 1974 |
Some observations on the pathogenesis of Bartter's syndrome.
Topics: Adult; Aldosterone; Alkalosis; Angiotensin II; Blood Volume; Drug Therapy, Combination; Humans; Hype | 1973 |
Modern concepts in diuretic therapy.
Topics: Blood Volume; Creatinine; Diuretics; Drug Therapy, Combination; Humans; Hyperaldosteronism; Hyperten | 1974 |
Bradycardia-tachycardia syndrome: results in twenty-eight patients treated by combined pharmacologic therapy and pacemaker implantation.
Topics: Aged; Atropa belladonna; Atropine; Autopsy; Bradycardia; Digitalis Glycosides; Ephedrine; Female; He | 1974 |
Hypertension with renal impairment: influence of intensive therapy.
Topics: Adolescent; Adult; Chronic Disease; Creatinine; Diazoxide; Female; Glomerulonephritis; Humans; Hyper | 1974 |
Dosage regimens of antiarrhythmics. II. Applications.
Topics: Anti-Arrhythmia Agents; Heart Failure; Humans; Injections, Intravenous; Kidney Diseases; Lidocaine; | 1973 |
Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension.
Topics: Adult; Aged; Aldosterone; Antihypertensive Agents; Blood Pressure; Child; Female; Humans; Hypertensi | 1973 |
Letter: Propranolol in Bartter's syndrome.
Topics: Child; Diet; Humans; Hyperaldosteronism; Hypokalemia; Juxtaglomerular Apparatus; Kidney Diseases; Ma | 1974 |
Correlation of myocardial and renal necrosis with tissue electrolyte changes.
Topics: Animals; Calcium, Dietary; Catecholamines; Electrolytes; Kidney Diseases; Magnesium; Male; Metaramin | 1966 |